Literature DB >> 22651705

Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study.

Adam D Tarnoki1, David L Tarnoki, Pal Bata, Levente Littvay, Janos Osztovits, Gyorgy Jermendy, Kinga Karlinger, Agnes Lannert, Istvan Preda, Robert G Kiss, Andrea A Molnar, Zsolt Garami, Gyorgy Baffy, Viktor Berczi.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been linked to increased cardiovascular morbidity. However, genetic factors have an unclear role in this condition. AIMS: To analyse heritability of NAFLD and its association with abnormal vascular parameters in a large twin cohort.
METHODS: Anthropometric and lipid metabolic parameters were obtained from 208 adult Hungarian twins (63 monozygotic and 41 dizygotic pairs; 58 men and 150 women; age 43.7 ± 16.7 years). B-mode ultrasonography was performed to detect steatosis and categorize severity. Brachial and aortic augmentation indices and aortic pulse wave velocity were assessed using oscillometry (TensioMed Arteriograph). Carotid intima media thickness (IMT) was measured using ultrasonography on the proximal common, distal common and internal carotid arteries.
RESULTS: NAFLD was identified in 47 subjects (22.6%), of which 44 (93.6%) had mild and 3 (6.4%) had moderate steatosis. These subjects were older (age: 50.9 ± 14.3 vs. 41.5 ± 16.7 years, P < 0.001) and had a higher body mass index (BMI; 30.1 ± 5.2 vs. 24.6 ± 4.1 km/m(2) , P < 0.001) than non-NAFLD twins. Based on 91 same-sex twin pairs, heritability analysis indicated no discernible role for genetic components in the presence of NAFLD (95% confidence interval, 0.0-36.0%), while shared and unshared environmental effects accounted for 74.2% and 25.8% of variations adjusted for age and BMI. Augmentation indices and carotid IMT in twins with NAFLD were increased at most examined locations (P < 0.05-P < 0.001).
CONCLUSION: These findings do not support heritability of NAFLD, although it coexists with vascular parameters linked to increased cardiovascular risk, underscoring the importance and value of prevention in this very common disorder.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22651705     DOI: 10.1111/j.1478-3231.2012.02823.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  14 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

Review 2.  Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.

Authors:  Johanna K DiStefano
Journal:  Cell Mol Life Sci       Date:  2020-06       Impact factor: 9.261

Review 3.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

4.  Assessing genetic and environmental influences on epicardial and abdominal adipose tissue quantities: a classical twin study.

Authors:  A L Jermendy; M Kolossvary; Z D Drobni; A D Tarnoki; D L Tarnoki; J Karady; S Voros; H J Lamb; B Merkely; G Jermendy; P Maurovich-Horvat
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

Review 5.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial.

Authors:  Hassan Solhi; Ramin Ghahremani; Amir Mohammad Kazemifar; Zahra Hoseini Yazdi
Journal:  Caspian J Intern Med       Date:  2014

7.  Antihyperlipidemic Effects of Sour Cherries Characterized by Different In Vitro Antioxidant Power and Polyphenolic Composition.

Authors:  Nóra Papp; Anna Blázovics; Hedvig Fébel; Sofía Salido; Joaquín Altarejos; Erzsébet Fehér; Ibolya Kocsis; Klára Szentmihályi; László Abrankó; Attila Hegedűs; Éva Stefanovits-Bányai
Journal:  Plant Foods Hum Nutr       Date:  2015-12       Impact factor: 3.921

8.  Rationale, Design, and Methodological Aspects of the BUDAPEST-GLOBAL Study (Burden of Atherosclerotic Plaques Study in Twins-Genetic Loci and the Burden of Atherosclerotic Lesions).

Authors:  Pál Maurovich-Horvat; Dávid L Tárnoki; Ádám D Tárnoki; Tamás Horváth; Ádám L Jermendy; Márton Kolossváry; Bálint Szilveszter; Viktor Voros; Attila Kovács; Andrea Á Molnár; Levente Littvay; Hildo J Lamb; Szilard Voros; György Jermendy; Béla Merkely
Journal:  Clin Cardiol       Date:  2015-10-23       Impact factor: 2.882

Review 9.  KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2013-12-28

10.  Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Authors:  Paola Dongiovanni; Quentin M Anstee; Luca Valenti
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.